Skip to content

Acupuncture for chronic atrophic gastritis with epigastric discomfort: A multicenter randomized controlled clinical trial

Acupuncture for chronic atrophic gastritis with epigastric discomfort: A multicenter randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069291
Enrollment
Unknown
Registered
2023-03-12
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic atrophic gastritis

Interventions

Acupuncture Group:Basic treatment+health education+acupuncture
Sham Acupuncture Group:Basic treatment+health education+sham acupuncture

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for chronic atrophic gastritis; 2. Present with one or both of the discomfort symptoms of abdominal pain or bloating in the past week, and one or both symptoms are at least moderately severe (overall symptom score >=4); 3. Aged 18-75 years, no gender limit; 4. Understand and agree to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Autoimmune gastritis (chronic atrophic gastritis type A); 2. Positive C-13 urea breath test at enrollment (Hp infected); 3. Patients diagnosed with gastroesophageal reflux disease (GERD) by endoscopy or other examination; 4. Patients with diagnosed or unable to rule out malignant tumors, especially esophageal and gastric cancers; Patients with peptic ulcer or other upper digestive tract lesions such as Barrett's esophagus; 5. Patients with serious lesions in vital organs of the whole body (heart, liver, kidney, lung, etc.); 6. Pregnant and lactating patients; 7. Patients with infectious diseases such as tuberculosis, hepatitis and AIDS; 8. A history of alcohol, drug or illicit drug use; 9. Patients who have used other stomach-stimulating agents, mucosal protective agents or acid suppressors in the past 2 weeks; 10. Have received acupuncture therapy or are participating in other clinical research projects.

Design outcomes

Primary

MeasureTime frame
Abdominal pain and bloating symptom relief rate;

Secondary

MeasureTime frame
Overall symptom score;Pepsinogen?, ?;Gastrin-17;Operative link on gastritis assessment;Operative link on gastric intestinal metaplasia assessment;Self-rating Anxiety Scale;Self-rating Depression Scale;12-item Short-form Health Survey;Safety assessment;

Countries

China

Contacts

Public ContactWu Huan'gan

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

wuhuangna@126.com+86 13601611239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026